ストックスクリーナーアプリを入手
2.94
6.07%
-0.19
アフターアワーズ：
2.92
-0.02
-0.68%
前日終値:
$3.13
開ける：
$3.1
24時間の取引高:
50,634
Relative Volume:
6.29
時価総額：
$9.88M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+22.50%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.81
$3.17
1週間の範囲:
$2.30
$3.2499
52週間の値動き範囲:
$2.0975
$3.2499
Gridai Technologies Corp Stock (GRDX) Company Profile
GRDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRDX
Gridai Technologies Corp
|
2.94 | 10.52M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gridai Technologies Corp (GRDX) 最新ニュース
Entero Regains Nasdaq Compliance With Grid AI Acquisition - Monroe Evening News
GridAI Technologies Corp. Announces Appointment of Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - Black Hills Pioneer
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Lohud
GridAI Technologies Announces Board Changes and Rebranding - The Globe and Mail
GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary - Yahoo Finance
GridAI Technologies Corp. Announces Board and Committee Changes - marketscreener.com
GridAI Technologies Corp. Appoints Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - marketscreener.com
GridAI Technologies (NASDAQ: GRDX) taps Marshall Chapin to lead AI data-center grid unit - Stock Titan
Entero Therapeutics Stock Gains 5% Ahead Of Name Change To GridAI - Nasdaq
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN
Entero Therapeutics (ENTO) to Rebrand as GridAI (GRDX) Technologies - GuruFocus
Entero Therapeutics to Change Name to GridAI Technologies - marketscreener.com
Entero Therapeutics stock rises ahead of name change to GridAI By Investing.com - Investing.com South Africa
Entero Therapeutics stock rises ahead of name change to GridAI - Investing.com India
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - Greenville Online
Entero (NASDAQ: ENTO) Grid AI LOI with First Hyperscaler AI Data-Center Client - Stock Titan
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid - St. Cloud Times
Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid - Record Searchlight
Entero Therapeutics (NASDAQ: ENTO) to name U.S. CEO and Executive Chairman for Grid AI - Stock Titan
Entero Therapeutics (NASDAQ: ENTO) acquires 100% of Grid AI, regains Nasdaq compliance - Stock Titan
$2.5B market opportunity: Entero Therapeutics acquires GRID AI to scale grid orchestration - Stock Titan
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand - Yahoo Finance
Entero Therapeutics Plans 1:3 Reverse Split as Shares Drop Below Nasdaq Minimum - Stock Titan
Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules - Stock Titan
Entero Therapeutics, Inc. Chief Financial Officer Changes - marketscreener.com
Entero Therapeutics Appoints Richard Paolone as CEO - marketscreener.com
Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members - marketscreener.com
Entero Therapeutics, Inc. announced that it has received $2 million in funding from 1396974 B.C. Ltd - marketscreener.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAF, ATSG, ENTO, AVTE on Behalf of Shareholders - marketscreener.com
Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum - marketscreener.com
Entero Therapeutics Announces 99% Reverse Merger Deal with Journey's Cancer Platform - Stock Titan
Journey Therapeutics, Inc. entered into a binding term sheet to acquire Entero Therapeutics, Inc. in a reverse merger transaction. - marketscreener.com
Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings - marketscreener.com
Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q - marketscreener.com
Entero Therapeutics Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - marketscreener.com
Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - marketscreener.com
ENTOEntero Therapeutics Latest Stock News & Market Updates - Stock Titan
First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase - marketscreener.com
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference - marketscreener.com
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico - marketscreener.com
First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders - marketscreener.com
Gridai Technologies Corp (GRDX) 財務データ
Gridai Technologies Corp (GRDX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):